Quantum Biopharma (QNTM) Shares Outstanding (2019 - 2026)
Quantum Biopharma (QNTM) posted Shares Outstanding (Entity) of $4.5 million for Q1 2026, up 15.48% sequentially from $3.9 million in Q4 2025, and up 65.6% YoY from $2.7 million in Q1 2025.
Quantum Biopharma (QNTM) Shares Outstanding (2019 - 2026) Analysis & Trends
Quantum Biopharma has reported Shares Outstanding (Entity) for 9 years, with the latest figure at $4.5 million in Q1 2026.
- Quarterly Shares Outstanding (Entity) rose 65.6% year-over-year to $4.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.5 million (up 65.6% YoY) and the FY2025 annual result came in at $3.9 million, up 241.95% from the prior year.
- Shares Outstanding (Entity) climbed to $4.5 million in Q1 2026 per QNTM's latest filing, from $3.9 million in the prior quarter.
- Over five years, Shares Outstanding (Entity) peaked at $47.4 million in Q2 2024 and troughed at $5.0 in Q2 2022.
- A 5-year average of $4.4 million and a median of $769920.5 in 2024 frame the typical range for Shares Outstanding (Entity).
- The sharpest annual moves came in 2024 and 2025: Shares Outstanding (Entity) soared 790139650.0% in 2024, then sank 92.68% in 2025.
- Over 5 years, Shares Outstanding (Entity) stood at $595704.0 in 2022, then increased by 2.24% to $609056.0 in 2023, then soared by 86.67% to $1.1 million in 2024, then jumped by 241.95% to $3.9 million in 2025, then rose by 15.48% to $4.5 million in 2026.
- According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $4.5 million, $3.9 million, and $3.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 62.19 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 398.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 111.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 133.61 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 241.70 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 217.35 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 445.06 Mn |
| 10 | Quantum Biopharma | 15.44 Mn | 11.80 Mn | - | 4.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.29 Mn |
| Mar 31, 2026 | 4.49 Mn |
| Dec 31, 2025 | 3.29 Mn |
| Sep 30, 2025 | 3.80 Mn |
| Jun 30, 2025 | 3.02 Mn |
| Mar 31, 2025 | 2.47 Mn |
| Dec 31, 2024 | 1.14 Mn |
| Sep 30, 2024 | 917,848.00 |
| Jun 30, 2024 | 41.68 Mn |
| Mar 31, 2024 | 610,035.00 |
| Dec 31, 2023 | 609,056.00 |
| Sep 30, 2023 | 6.00 |
| Jun 30, 2023 | 6.00 |
| Mar 31, 2023 | 599,242.00 |
| Dec 31, 2022 | 595,704.00 |
| Sep 30, 2022 | 8.00 |
| Jun 30, 2022 | 5.00 |
| Mar 31, 2022 | 537,457.00 |
| Dec 31, 2021 | 537,457.00 |
| Sep 30, 2021 | 13.00 |